Key result
Higher estimated sdLDL-C linked to ~25% greater risk of incident ASCVD hospitalization.
Why the study?
Integration of small dense LDL cholesterol into routine ASCVD risk assessments remains limited due to additional lipid testing requirements, despite its known atherogenicity.
Does higher estimated sdLDL-C predict incident ASCVD hospitalization in adults?
Cohort (n=1,884,758)
Does higher estimated sdLDL-C predict incident ASCVD hospitalization in adults?
Hazard Ratio: 1.25 (95% CI 1.2–1.31)
Estimated small dense LDL-C (calculated via the Sampson formula) is an independent predictor of incident ASCVD hospitalization in a large Japanese cohort, potentially improving risk stratification even in patients with low overall LDL-C.
Background Small dense low-density lipoprotein cholesterol (sdLDL-C) is an atherogenic LDL-C subfraction associated with atherosclerotic cardiovascular disease (ASCVD). Although sdLDL-C integration into major routine risk assessments remains limited partly due to requiring additional lipid tests, a more implementable estimated sdLDL-C equation was recently developed. Objective This study aimed to evaluate the association between estimated sdLDL-C and incident ASCVD in a health checkup population of Japanese adults. Methods Using the DeSC database in Japan, this study included adults aged 40-74 years who underwent health checkups between April 2014 and March 2023. Estimated sdLDL-C was calculated via the Sampson formula, and the primary outcome was first incident ASCVD hospitalization via claims data. Estimated sdLDL-C was categorized into quartiles, and associations with incident ASCVD were evaluated using Cox regression models adjusted for sex, age, BMI, hypertension, diabetes, smoking, alcohol, low HDL-C, high LDL-C, lipid-lowering medication, and fasting time. Subgroup analyses were conducted by LDL-C, sex, age, and ASCVD subtypes. Results Among 1,884,758 participants, 22,596 incident ASCVD events were observed. The Cox model showed ASCVD risk increased across estimated sdLDL-C quartiles, with a hazard ratio of 1.25 [1.20-1.31] for Q4. This association largely continued across sex, age, LDL-C, and ASCVD subtype subgroups, with stronger associations observed in male participants, for CAD than ischemic stroke, among younger individuals, and those with higher LDL-C. Conclusion Higher estimated sdLDL-C was associated with increased ASCVD risk, including among individuals with low LDL-C. Estimated sdLDL-C may improve ASCVD risk stratification beyond LDL-C and inform further primary prevention strategies.
No takes yet. Share an insight, caveat, or question.
Ono et al. (2026) conducted a cohort in Atherosclerotic cardiovascular disease (ASCVD) (n=1,884,758). Estimated small dense low-density lipoprotein cholesterol (sdLDL-C) vs. Lower quartiles of estimated sdLDL-C was evaluated on First incident ASCVD hospitalization (HR 1.25, 95% CI 1.20-1.31). Higher estimated sdLDL-C (quartile 4) was associated with an increased risk of incident ASCVD hospitalization (HR 1.25; 95% CI 1.20-1.31).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: